Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 26, 2026
Etzer Darout's Stock Ratings
Barclays Analyst
Etzer Darout is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
19.0%
Smart Score
Overall Average Return Percentile
75th
Number of Ratings
235
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/21/2026 | TRAX | Buy Now | First Tracks | $35.52 | 35.14% | $40 → $48 | Maintains | Overweight | Get Alert | |
| 07/21/2026 | FBRX | Buy Now | Forte Biosciences | $54.00 | 37.04% | → $74 | Initiates | → Overweight | Get Alert | |
| 07/14/2026 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | 10.94% | $119 → $151 | Maintains | Overweight | Get Alert | |
| 07/14/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | 2.41% | $253 → $260 | Maintains | Overweight | Get Alert | |
| 07/14/2026 | INCY | Buy Now | Incyte | $117.00 | 14.53% | $117 → $134 | Maintains | Overweight | Get Alert | |
| 07/14/2026 | EXEL | Buy Now | Exelixis | $55.37 | -11.5% | $45 → $49 | Maintains | Equal-Weight | Get Alert | |
| 06/10/2026 | NUVL | Buy Now | Nuvalent | — | — | $152 → $124 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/27/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -0.34% | $234 → $253 | Maintains | Overweight | Get Alert | |
| 05/20/2026 | RLAY | Buy Now | Relay Therapeutics | $18.11 | 49.09% | $21 → $27 | Maintains | Overweight | Get Alert | |
| 05/13/2026 | ARVN | Buy Now | Arvinas | $8.03 | 149.07% | $18 → $20 | Maintains | Overweight | Get Alert | |
| 05/13/2026 | ANAB | Buy Now | AnaptysBio | $54.15 | 38.5% | $63 → $75 | Maintains | Overweight | Get Alert | |
| 05/08/2026 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | 15.38% | $53 → $55 | Maintains | Overweight | Get Alert | |
| 05/08/2026 | CLDX | Buy Now | Celldex Therapeutics | $35.28 | 36.05% | $45 → $48 | Maintains | Overweight | Get Alert | |
| 05/06/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -7.83% | $225 → $234 | Maintains | Overweight | Get Alert | |
| 05/01/2026 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.70 | 78.74% | $35 → $37 | Maintains | Overweight | Get Alert | |
| 04/28/2026 | ORKA | Buy Now | Oruka Therapeutics | $92.16 | 73.61% | $78 → $160 | Maintains | Overweight | Get Alert | |
| 04/22/2026 | ANAB | Buy Now | AnaptysBio | $54.15 | 16.34% | $79 → $63 | Maintains | Overweight | Get Alert | |
| 04/22/2026 | TRAX | Buy Now | First Tracks | $35.52 | 12.61% | → $40 | Initiates | → Overweight | Get Alert | |
| 04/20/2026 | MGNX | Buy Now | Macrogenics | $3.63 | 65.29% | $4 → $6 | Maintains | Overweight | Get Alert | |
| 04/20/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -11.37% | $224 → $225 | Maintains | Overweight | Get Alert | |
| 04/20/2026 | EXEL | Buy Now | Exelixis | $55.37 | -18.73% | $44 → $45 | Maintains | Equal-Weight | Get Alert | |
| 04/20/2026 | TVRD | Buy Now | Tvardi Therapeutics | $2.51 | 19.52% | $4 → $3 | Downgrade | Equal-Weight → Underweight | Get Alert | |
| 04/20/2026 | JANX | Buy Now | Janux Therapeutics | $15.33 | -8.68% | $29 → $14 | Downgrade | Overweight → Underweight | Get Alert | |
| 04/20/2026 | CLDX | Buy Now | Celldex Therapeutics | $35.28 | 27.55% | $24 → $45 | Upgrade | Underweight → Overweight | Get Alert | |
| 04/08/2026 | RLAY | Buy Now | Relay Therapeutics | $18.11 | 15.96% | $17 → $21 | Maintains | Overweight | Get Alert | |
| 04/07/2026 | ORKA | Buy Now | Oruka Therapeutics | $92.16 | -15.36% | $50 → $78 | Maintains | Overweight | Get Alert | |
| 04/01/2026 | TVRD | Buy Now | Tvardi Therapeutics | $2.51 | 59.36% | $5 → $4 | Maintains | Equal-Weight | Get Alert | |
| 03/30/2026 | TERN | Buy Now | Terns Pharma | — | — | $56 → $53 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/24/2026 | ABVX | Buy Now | Abivax | $125.90 | 17.55% | $142 → $148 | Maintains | Overweight | Get Alert | |
| 03/19/2026 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -12.57% | $113 → $119 | Maintains | Overweight | Get Alert | |
| 03/19/2026 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 393.83% | $10 → $16 | Maintains | Overweight | Get Alert | |
| 03/13/2026 | ORKA | Buy Now | Oruka Therapeutics | $92.16 | -45.75% | $48 → $50 | Maintains | Overweight | Get Alert | |
| 03/11/2026 | BNTX | Buy Now | BioNTech | $89.50 | 43.02% | $143 → $128 | Maintains | Outperform | Get Alert | |
| 03/10/2026 | MGNX | Buy Now | Macrogenics | $3.63 | 10.19% | $3 → $4 | Maintains | Overweight | Get Alert | |
| 03/04/2026 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | 46.84% | $50 → $70 | Maintains | Outperform | Get Alert | |
| 03/04/2026 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | 11.18% | $52 → $53 | Maintains | Overweight | Get Alert | |
| 03/04/2026 | ANAB | Buy Now | AnaptysBio | $54.15 | 45.89% | $78 → $79 | Maintains | Overweight | Get Alert | |
| 02/27/2026 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 105.28% | $5 → $7 | Maintains | Overweight | Get Alert | |
| 02/27/2026 | JAZZ | Buy Now | Jazz Pharmaceuticals | $253.87 | -11.77% | → $224 | Initiates | → Overweight | Get Alert | |
| 02/26/2026 | XNCR | Buy Now | Xencor | $19.44 | 38.89% | $26 → $27 | Maintains | Overweight | Get Alert | |
| 02/26/2026 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -16.98% | $108 → $113 | Maintains | Overweight | Get Alert | |
| 02/25/2026 | VIR | Buy Now | Vir Biotechnology | $8.74 | 243.25% | $26 → $30 | Maintains | Overweight | Get Alert | |
| 02/25/2026 | IOVA | Buy Now | Iovance Biotherapeutics | $5.00 | 120% | $10 → $11 | Maintains | Overweight | Get Alert | |
| 02/18/2026 | INCY | Buy Now | Incyte | $117.00 | — | $116 → $117 | Maintains | Overweight | Get Alert | |
| 02/04/2026 | INCY | Buy Now | Incyte | $117.00 | -0.85% | $115 → $116 | Maintains | Overweight | Get Alert | |
| 02/04/2026 | EXEL | Buy Now | Exelixis | $55.37 | -20.53% | $41 → $44 | Maintains | Equal-Weight | Get Alert | |
| 02/04/2026 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 208.64% | $8 → $10 | Maintains | Overweight | Get Alert | |
| 01/28/2026 | KYMR | Buy Now | Kymera Therapeutics | $110.57 | 20.29% | $119 → $133 | Maintains | Overweight | Get Alert | |
| 01/21/2026 | RAPT | Buy Now | RAPT Therapeutics | — | — | → $58 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/21/2026 | CRVS | Buy Now | Corvus Pharma | $13.15 | 112.93% | $16 → $28 | Maintains | Overweight | Get Alert | |
| 01/20/2026 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 146.91% | $6 → $8 | Maintains | Overweight | Get Alert | |
| 01/20/2026 | ANAB | Buy Now | AnaptysBio | $54.15 | 44.04% | $55 → $78 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | XNCR | Buy Now | Xencor | $19.44 | 33.74% | $23 → $26 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | 9.08% | $45 → $52 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -20.65% | $88 → $108 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | JANX | Buy Now | Janux Therapeutics | $15.33 | 89.17% | $48 → $29 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $5.00 | 100% | $9 → $10 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | CLDX | Buy Now | Celldex Therapeutics | $35.28 | -31.97% | $21 → $24 | Maintains | Underweight | Get Alert | |
| 12/17/2025 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 46.63% | $10 → $5 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | ARVN | Buy Now | Arvinas | $8.03 | 124.16% | $16 → $18 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | ANAB | Buy Now | AnaptysBio | $54.15 | 1.57% | $70 → $55 | Maintains | Overweight | Get Alert | |
| 12/17/2025 | SMMT | Buy Now | Summit Therapeutics | $13.66 | 31.77% | $16 → $18 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 12/09/2025 | TERN | Buy Now | Terns Pharma | — | — | $36 → $56 | Maintains | Overweight | Get Alert | |
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $110.57 | 7.62% | $70 → $119 | Maintains | Overweight | Get Alert | |
| 11/25/2025 | TERN | Buy Now | Terns Pharma | — | — | $28 → $36 | Maintains | Overweight | Get Alert | |
| 11/24/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.70 | 69.08% | $22 → $35 | Maintains | Overweight | Get Alert | |
| 11/24/2025 | KURA | Buy Now | Kura Oncology | $10.43 | 168.46% | $11 → $28 | Maintains | Overweight | Get Alert | |
| 11/24/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $5.00 | 80% | $4 → $9 | Maintains | Overweight | Get Alert | |
| 11/24/2025 | INCY | Buy Now | Incyte | $117.00 | -1.71% | $101 → $115 | Maintains | Overweight | Get Alert | |
| 11/17/2025 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -5.6% | $44 → $45 | Maintains | Overweight | Get Alert | |
| 11/11/2025 | TERN | Buy Now | Terns Pharma | — | — | $27 → $28 | Maintains | Overweight | Get Alert | |
| 11/11/2025 | CLDX | Buy Now | Celldex Therapeutics | $35.28 | -40.48% | $25 → $21 | Maintains | Underweight | Get Alert | |
| 11/11/2025 | ANAB | Buy Now | AnaptysBio | $54.15 | 29.27% | $83 → $70 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | RAPT | Buy Now | RAPT Therapeutics | — | — | $58 → $56 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -35.35% | $72 → $88 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | JANX | Buy Now | Janux Therapeutics | $15.33 | 213.11% | $47 → $48 | Maintains | Overweight | Get Alert | |
| 11/06/2025 | ARVN | Buy Now | Arvinas | $8.03 | 99.25% | $15 → $16 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | KYMR | Buy Now | Kymera Therapeutics | $110.57 | -36.69% | $60 → $70 | Maintains | Overweight | Get Alert | |
| 11/05/2025 | EXEL | Buy Now | Exelixis | $55.37 | -25.95% | $40 → $41 | Maintains | Equal-Weight | Get Alert | |
| 11/04/2025 | TERN | Buy Now | Terns Pharma | — | — | $14 → $27 | Maintains | Overweight | Get Alert | |
| 10/29/2025 | XNCR | Buy Now | Xencor | $19.44 | 18.31% | $6 → $23 | Upgrade | Underweight → Overweight | Get Alert | |
| 10/22/2025 | TERN | Buy Now | Terns Pharma | — | — | $15 → $14 | Maintains | Overweight | Get Alert | |
| 10/21/2025 | SMMT | Buy Now | Summit Therapeutics | $13.66 | 17.13% | $13 → $16 | Maintains | Underweight | Get Alert | |
| 10/21/2025 | RAPT | Buy Now | RAPT Therapeutics | — | — | $35 → $58 | Maintains | Overweight | Get Alert | |
| 10/21/2025 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 85.19% | $3.5 → $6 | Maintains | Overweight | Get Alert | |
| 10/13/2025 | CLDX | Buy Now | Celldex Therapeutics | $35.28 | -29.14% | → $25 | Initiates | → Underweight | Get Alert | |
| 10/13/2025 | TVRD | Buy Now | Tvardi Therapeutics | $2.51 | 2330.28% | → $61 | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | RAPT | Buy Now | RAPT Therapeutics | — | — | → $35 | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | ORKA | Buy Now | Oruka Therapeutics | $92.16 | -47.92% | → $48 | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | MNPR | Buy Now | Monopar Therapeutics | $105.54 | 18.44% | → $125 | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | CRVS | Buy Now | Corvus Pharma | $13.15 | 21.67% | → $16 | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | ANAB | Buy Now | AnaptysBio | $54.15 | 44.04% | → $78 | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | ABVX | Buy Now | Abivax | $125.90 | 12.79% | → $142 | Initiates | → Overweight | Get Alert | |
| 09/30/2025 | MRUS | Buy Now | Merus | — | — | $112 → $97 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 09/24/2025 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -7.7% | $45 → $44 | Maintains | Overweight | Get Alert | |
| 09/23/2025 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 193.26% | $8 → $10 | Maintains | Overweight | Get Alert | |
| 09/17/2025 | XNCR | Buy Now | Xencor | $19.44 | -69.14% | → $6 | Assumes | → Underweight | Get Alert | |
| 09/17/2025 | MGNX | Buy Now | Macrogenics | $3.63 | -17.36% | → $3 | Assumes | → Overweight | Get Alert | |
| 09/17/2025 | EXEL | Buy Now | Exelixis | $55.37 | -27.76% | → $40 | Initiates | → Equal-Weight | Get Alert | |
| 09/17/2025 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 8.02% | → $3.5 | Assumes | → Overweight | Get Alert | |
| 09/17/2025 | ARVN | Buy Now | Arvinas | $8.03 | 99.25% | → $16 | Assumes | → Overweight | Get Alert | |
| 09/17/2025 | TERN | Buy Now | Terns Pharma | — | — | → $15 | Initiates | → Overweight | Get Alert | |
| 09/17/2025 | SMMT | Buy Now | Summit Therapeutics | $13.66 | -4.83% | → $13 | Initiates | → Underweight | Get Alert | |
| 09/17/2025 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -5.6% | → $45 | Initiates | → Overweight | Get Alert | |
| 09/17/2025 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -47.1% | → $72 | Initiates | → Overweight | Get Alert | |
| 09/17/2025 | MRUS | Buy Now | Merus | — | — | → $112 | Initiates | → Overweight | Get Alert | |
| 09/17/2025 | KYMR | Buy Now | Kymera Therapeutics | $110.57 | -45.74% | → $60 | Initiates | → Overweight | Get Alert | |
| 09/17/2025 | JANX | Buy Now | Janux Therapeutics | $15.33 | 206.59% | → $47 | Initiates | → Overweight | Get Alert | |
| 09/17/2025 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 134.6% | → $8 | Initiates | → Overweight | Get Alert | |
| 09/02/2025 | IVA | Buy Now | Inventiva | $4.46 | 191.48% | $9 → $13 | Maintains | Buy | Get Alert | |
| 08/07/2025 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -5.6% | $57 → $45 | Maintains | Outperform | Get Alert | |
| 05/13/2025 | TERN | Buy Now | Terns Pharma | — | — | $26 → $15 | Maintains | Outperform | Get Alert | |
| 04/15/2025 | VERV | Buy Now | Verve Therapeutics | — | — | $18 → $24 | Maintains | Buy | Get Alert | |
| 04/04/2025 | IVA | Buy Now | Inventiva | $4.46 | 101.79% | $12 → $9 | Maintains | Buy | Get Alert | |
| 03/12/2025 | ARVN | Buy Now | Arvinas | $8.03 | 149.07% | $82 → $20 | Maintains | Outperform | Get Alert | |
| 03/11/2025 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -47.1% | $62 → $72 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/11/2025 | BNTX | Buy Now | BioNTech | $89.50 | 59.78% | $130 → $143 | Maintains | Outperform | Get Alert | |
| 02/28/2025 | MRUS | Buy Now | Merus | — | — | $91 → $96 | Maintains | Outperform | Get Alert | |
| 02/12/2025 | ARVN | Buy Now | Arvinas | $8.03 | 921.17% | $88 → $82 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/11/2025 | QTTB | Buy Now | Q32 Bio | $15.41 | -80.53% | $22 → $3 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/10/2025 | IGMS | Buy Now | IGM Biosciences | — | — | $21 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/20/2024 | EXEL | Buy Now | Exelixis | $55.37 | -27.76% | $36 → $40 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/12/2024 | QTTB | Buy Now | Q32 Bio | $15.41 | 42.76% | $64 → $22 | Maintains | Outperform | Get Alert | |
| 12/06/2024 | QTTB | Buy Now | Q32 Bio | $15.41 | 315.31% | → $64 | Initiates | → Outperform | Get Alert | |
| 12/06/2024 | TRML | Buy Now | Tourmaline Bio | — | — | → $50 | Initiates | → Outperform | Get Alert | |
| 12/06/2024 | PTGX | Buy Now | Protagonist Therapeutics | $136.11 | -54.45% | → $62 | Initiates | → Outperform | Get Alert | |
| 12/06/2024 | NRIX | Buy Now | Nurix Therapeutics | $23.38 | 49.7% | → $35 | Initiates | → Outperform | Get Alert | |
| 12/06/2024 | KYMR | Buy Now | Kymera Therapeutics | $110.57 | -50.26% | → $55 | Initiates | → Market Perform | Get Alert | |
| 12/06/2024 | IGMS | Buy Now | IGM Biosciences | — | — | → $21 | Initiates | → Outperform | Get Alert | |
| 12/06/2024 | JSPR | Buy Now | Jasper Therapeutics | $0.69 | 9030.43% | → $63 | Initiates | → Outperform | Get Alert | |
| 11/20/2024 | ARVN | Buy Now | Arvinas | $8.03 | 995.89% | $90 → $88 | Maintains | Outperform | Get Alert | |
| 11/14/2024 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 1498.77% | $28 → $27 | Maintains | Outperform | Get Alert | |
| 11/13/2024 | NUVL | Buy Now | Nuvalent | — | — | $132 → $134 | Maintains | Outperform | Get Alert | |
| 11/08/2024 | XNCR | Buy Now | Xencor | $19.44 | 74.9% | $32 → $34 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/08/2024 | GMAB | Buy Now | Genmab | $28.87 | 66.26% | $46 → $48 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/30/2024 | NVS | Buy Now | Novartis | $155.01 | -22.59% | $118 → $120 | Maintains | Market Perform | Get Alert | |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $55.37 | -34.98% | $29 → $36 | Maintains | Outperform | Get Alert | |
| 10/11/2024 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -20.29% | $34 → $38 | Maintains | Outperform | Get Alert | |
| 09/16/2024 | TERN | Buy Now | Terns Pharma | — | — | $19 → $26 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/16/2024 | NUVL | Buy Now | Nuvalent | — | — | $102 → $132 | Maintains | Outperform | Get Alert | |
| 09/16/2024 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 1557.98% | $25 → $28 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/13/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $26 → $25 | Maintains | Outperform | Get Alert | |
| 08/09/2024 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -28.68% | $31 → $34 | Maintains | Outperform | Get Alert | |
| 08/07/2024 | MGNX | Buy Now | Macrogenics | $3.63 | 37.74% | $8 → $5 | Maintains | Market Perform | Get Alert | |
| 08/06/2024 | XNCR | Buy Now | Xencor | $19.44 | 64.61% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/06/2024 | TERN | Buy Now | Terns Pharma | — | — | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/06/2024 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 486.51% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/14/2024 | XNCR | Buy Now | Xencor | $19.44 | 64.61% | $34 → $32 | Maintains | Outperform | Get Alert | |
| 06/13/2024 | SRRK | Buy Now | Scholar Rock Holding | $47.67 | -34.97% | $29 → $31 | Maintains | Outperform | Get Alert | |
| 06/04/2024 | MRUS | Buy Now | Merus | — | — | $84 → $91 | Maintains | Outperform | Get Alert | |
| 05/15/2024 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 1380.34% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/10/2024 | FATE | Buy Now | Fate Therapeutics | $2.42 | 147.92% | $7 → $6 | Maintains | Market Perform | Get Alert | |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $3.63 | 120.39% | $24 → $8 | Downgrade | Outperform → Market Perform | Get Alert | |
| 05/09/2024 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 10.8% | $3.25 → $3.59 | Maintains | Market Perform | Get Alert | |
| 05/07/2024 | BNTX | Buy Now | BioNTech | $89.50 | 36.31% | $123 → $122 | Maintains | Outperform | Get Alert | |
| 05/01/2024 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 0.31% | $3.25 → $3.25 | Reiterates | Market Perform → Market Perform | Get Alert | |
| 04/26/2024 | AZN | Buy Now | AstraZeneca | $168.01 | -51.19% | $80 → $82 | Maintains | Outperform | Get Alert | |
| 04/26/2024 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 1380.34% | $18 → $25 | Maintains | Outperform | Get Alert | |
| 04/24/2024 | NVS | Buy Now | Novartis | $155.01 | -25.17% | $114 → $116 | Maintains | Market Perform | Get Alert | |
| 04/01/2024 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 965.85% | → $18 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/21/2024 | BNTX | Buy Now | BioNTech | $89.50 | 37.43% | $127 → $123 | Maintains | Outperform | Get Alert | |
| 03/15/2024 | TERN | Buy Now | Terns Pharma | — | — | $18 → $19 | Maintains | Outperform | Get Alert | |
| 03/12/2024 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 0.31% | $3.3 → $3.25 | Maintains | Market Perform | Get Alert | |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $3.63 | 561.16% | $18 → $24 | Maintains | Outperform | Get Alert | |
| 03/04/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $16 → $26 | Maintains | Outperform | Get Alert | |
| 02/29/2024 | MRUS | Buy Now | Merus | — | — | $49 → $58 | Maintains | Outperform | Get Alert | |
| 02/28/2024 | NUVL | Buy Now | Nuvalent | — | — | $93 → $102 | Maintains | Outperform | Get Alert | |
| 02/28/2024 | ARVN | Buy Now | Arvinas | $8.03 | 1020.8% | $89 → $90 | Maintains | Outperform | Get Alert | |
| 02/28/2024 | XNCR | Buy Now | Xencor | $19.44 | 74.9% | $38 → $34 | Maintains | Outperform | Get Alert | |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $2.42 | 189.24% | $6 → $7 | Maintains | Market Perform | Get Alert | |
| 02/23/2024 | NVS | Buy Now | Novartis | $155.01 | -26.46% | → $114 | Initiates | → Market Perform | Get Alert | |
| 02/23/2024 | BNTX | Buy Now | BioNTech | $89.50 | 41.9% | → $127 | Initiates | → Outperform | Get Alert | |
| 02/23/2024 | GMAB | Buy Now | Genmab | $28.87 | 66.26% | $46 → $48 | Upgrade | Market Perform → Outperform | Get Alert | |
| 02/12/2024 | AZN | Buy Now | AstraZeneca | $168.01 | -52.38% | $82 → $80 | Maintains | Outperform | Get Alert | |
| 12/01/2023 | IMGN | Buy Now | Immunogen | — | — | → $31 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/10/2023 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 1321.13% | $25 → $24 | Maintains | Outperform | Get Alert | |
| 11/09/2023 | FATE | Buy Now | Fate Therapeutics | $2.42 | 147.92% | $5.4 → $6 | Maintains | Market Perform | Get Alert | |
| 11/03/2023 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 369.21% | $18 → $16 | Maintains | Outperform | Get Alert | |
| 10/19/2023 | NUVL | Buy Now | Nuvalent | — | — | $73 → $79 | Maintains | Outperform | Get Alert | |
| 10/05/2023 | NUVL | Buy Now | Nuvalent | — | — | $52 → $73 | Maintains | Outperform | Get Alert | |
| 09/01/2023 | IVA | Buy Now | Inventiva | $4.46 | 169.06% | → $12 | Reiterates | Buy → Buy | Get Alert | |
| 08/09/2023 | FATE | Buy Now | Fate Therapeutics | $2.42 | 123.13% | $6 → $5.4 | Maintains | Market Perform | Get Alert | |
| 08/09/2023 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | -1.54% | $3.15 → $3.19 | Maintains | Market Perform | Get Alert | |
| 08/01/2023 | IMGN | Buy Now | Immunogen | — | — | $25 → $26 | Maintains | Outperform | Get Alert | |
| 08/01/2023 | AZN | Buy Now | AstraZeneca | $168.01 | -50.6% | $81 → $83 | Maintains | Outperform | Get Alert | |
| 05/08/2023 | TERN | Buy Now | Terns Pharma | — | — | → $18 | Initiates | → Outperform | Get Alert | |
| 05/08/2023 | ACRV | Buy Now | Acrivon Therapeutics | $1.69 | 1380.34% | → $25 | Initiates | → Outperform | Get Alert | |
| 04/25/2023 | FHTX | Buy Now | Foghorn Therapeutics | $4.90 | 287.76% | $20 → $19 | Maintains | Outperform | Get Alert | |
| 04/18/2023 | MRUS | Buy Now | Merus | — | — | $47 → $49 | Maintains | Outperform | Get Alert | |
| 04/03/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 03/16/2023 | MRUS | Buy Now | Merus | — | — | $46 → $47 | Maintains | Outperform | Get Alert | |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | $179 → $229 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/16/2023 | SGEN | Buy Now | Seagen | — | — | $177 → $179 | Maintains | Outperform | Get Alert | |
| 01/30/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $12 → $13 | Maintains | Outperform | Get Alert | |
| 01/06/2023 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | -1.23% | $2.6 → $3.2 | Maintains | Market Perform | Get Alert | |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $2.42 | 189.24% | $20 → $7 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/05/2023 | AZN | Buy Now | AstraZeneca | $168.01 | -51.19% | → $82 | Initiates | → Outperform | Get Alert | |
| 01/05/2023 | FHTX | Buy Now | Foghorn Therapeutics | $4.90 | 308.16% | → $20 | Initiates | → Outperform | Get Alert | |
| 11/16/2022 | IMGN | Buy Now | Immunogen | — | — | $17 → $19 | Maintains | Outperform | Get Alert | |
| 11/14/2022 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | -19.75% | $3 → $2.6 | Downgrade | Outperform → Market Perform | Get Alert | |
| 11/14/2022 | MGNX | Buy Now | Macrogenics | $3.63 | 340.77% | $5.7 → $16 | Upgrade | Market Perform → Outperform | Get Alert | |
| 11/01/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $29 → $12 | Maintains | Outperform | Get Alert | |
| 10/11/2022 | SGEN | Buy Now | Seagen | — | — | $177 → $178 | Upgrade | Market Perform → Outperform | Get Alert | |
| 07/12/2022 | FATE | Buy Now | Fate Therapeutics | $2.42 | 1842.07% | $50 → $47 | Upgrade | Market Perform → Outperform | Get Alert | |
| 07/12/2022 | MGNX | Buy Now | Macrogenics | $3.63 | 10.19% | $31 → $4 | Downgrade | Outperform → Market Perform | Get Alert | |
| 07/11/2022 | FATE | Buy Now | Fate Therapeutics | $2.42 | 1842.07% | → $47 | Upgrade | Market Perform → Outperform | Get Alert | |
| 07/11/2022 | MGNX | Buy Now | Macrogenics | $3.63 | 10.19% | $31 → $4 | Downgrade | Outperform → Market Perform | Get Alert | |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | -7.41% | $9 → $3 | Maintains | Outperform | Get Alert | |
| 06/24/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $27 | Initiates | → Outperform | Get Alert | |
| 06/24/2022 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 177.78% | → $9 | Initiates | → Outperform | Get Alert | |
| 06/24/2022 | EXEL | Buy Now | Exelixis | $55.37 | -49.43% | → $28 | Initiates | → Outperform | Get Alert | |
| 06/24/2022 | NUVL | Buy Now | Nuvalent | — | — | → $28 | Initiates | → Outperform | Get Alert | |
| 06/24/2022 | GMAB | Buy Now | Genmab | $28.87 | 20.3% | → $34.73 | Initiates | → Market Perform | Get Alert | |
| 06/24/2022 | SGEN | Buy Now | Seagen | — | — | → $169 | Initiates | → Market Perform | Get Alert | |
| 04/11/2022 | CCCC | Buy Now | C4 Therapeutics | $3.41 | 486.51% | $57 → $20 | Maintains | Outperform | Get Alert | |
| 02/11/2022 | IMGN | Buy Now | Immunogen | — | — | — | Initiates | → Outperform | Get Alert | |
| 02/11/2022 | XNCR | Buy Now | Xencor | $19.44 | — | — | Initiates | → Outperform | Get Alert | |
| 02/11/2022 | MRUS | Buy Now | Merus | — | — | → $45 | Initiates | → Outperform | Get Alert | |
| 02/11/2022 | MGNX | Buy Now | Macrogenics | $3.63 | 753.99% | → $31 | Initiates | → Outperform | Get Alert | |
| 02/03/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $271.40 | -37.36% | → $170 | Upgrade | Neutral → Buy | Get Alert | |
| 07/12/2021 | VERV | Buy Now | Verve Therapeutics | — | — | → $84 | Initiates | → Buy | Get Alert | |
| 05/18/2021 | ONTX | Buy Now | Onconova Therapeutics | $16.65 | -75.98% | → $4 | Initiates | → Buy | Get Alert | |
| 03/09/2021 | FPRX | Buy Now | Five Prime Therapeutics | — | — | → $38 | Downgrade | Buy → Neutral | Get Alert | |
| 02/26/2021 | AKRO | Buy Now | Akero Therapeutics | — | — | → $54 | Initiates | → Buy | Get Alert | |
| 02/22/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $271.40 | -40.31% | → $162 | Downgrade | Buy → Neutral | Get Alert | |
| 09/22/2020 | FPRX | Buy Now | Five Prime Therapeutics | — | — | → $11 | Upgrade | Neutral → Buy | Get Alert | |
| 09/22/2020 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 09/22/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 09/09/2020 | MIRM | Buy Now | Mirum Pharmaceuticals | $113.03 | -66.38% | $27 → $38 | Maintains | Buy | Get Alert | |
| 08/04/2020 | IVA | Buy Now | Inventiva | $4.46 | 482.96% | → $26 | Initiates | → Buy | Get Alert | |
| 06/01/2020 | MGNX | Buy Now | Macrogenics | $3.63 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 02/20/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | → $66 | Initiates | → Buy | Get Alert | |
| 11/20/2019 | MGNX | Buy Now | Macrogenics | $3.63 | — | — | Assumes | → Neutral | Get Alert | |
| 11/20/2019 | CTMX | Buy Now | CytomX Therapeutics | $3.24 | 393.83% | → $16 | Initiates | → Buy | Get Alert | |
| 10/01/2019 | FPRX | Buy Now | Five Prime Therapeutics | — | — | — | Downgrade | Buy → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved